MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
10.14
-0.27 (-2.59%)
At close: Oct 14, 2026, 4:00 PM EDT
10.14
0.00 (0.00%)
After-hours: Oct 14, 2026, 6:33 PM EDT
MLTX Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, MLTX stock has a consensus rating of "Buy" and an average price target of $28.54. The average 1-year stock price forecast is 181.46% higher than the current stock price, while the lowest is $6.00 (-40.83%) and the highest is $50 (+393.10%).
Price Target: $28.54 (+181.46%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for MLTX stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 10 | 10 | 10 | 10 | 10 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Total | 15 | 15 | 15 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Maintains $34 | Buy | Maintains | $34 | +235.31% | Oct 5, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $50 | Buy | Reiterates | $50 | +393.10% | Oct 5, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Oct 1, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates $30 | Buy | Reiterates | $30 | +195.86% | Oct 1, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $33 | Buy | Maintains | $33 | +225.44% | Sep 30, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
19.04M
EPS This Year
-3.38
from -3.53
EPS Next Year
-3.33
from -3.38
EPS and Forward PE are based on non-GAAP adjusted numbers.